Ewa Lech‐Marańda

7.8k citations
197 papers · 5.9k · 5 hit papers · h-index 33

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.5%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 89
    • Multiple Myeloma Research and Treatments 27
    • Chronic Myeloid Leukemia Treatments 20
    • Acute Myeloid Leukemia Research 19

Ewa Lech‐Marańda

177 papers receiving 5.8k citations

Ewa Lech‐Marańda's Hit Papers

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia 2023 · 164 citations
1640+3+6Years since publication50010001.5k

Peers

Ewa Lech‐Marańda
Comparison fields: 5 of 113
  • Genetics 1.6k
  • Hematology 1.4k
  • Pathology and Forensic Medicine 1.9k
  • Oncology 2.2k
  • Immunology 1.0k
Replace Krzysztof Warzocha with:
Krzysztof Warzocha Poland
Monica Bocchia Italy
Sarit E. Assouline Canada
G. Verhoef Belgium
Mark H. Kirschbaum United States
Su‐Peng Yeh Taiwan
Michinori Ogura Japan
Eckhart Weidmann Germany
Leslie L. Popplewell United States
Kazimierz Kuliczkowski Poland
Ewa Lech‐Marańda relative to Krzysztof Warzocha Poland Krzysztof Warzocha's profile →
Citations per field
00.5×2×3.3×
Krzysztof Warzocha · 1×
Citations per year

Countries citing papers authored by Ewa Lech‐Marańda

Since Specialization
Citations

This map shows the geographic impact of Ewa Lech‐Marańda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Lech‐Marańda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Lech‐Marańda more than expected).

Fields of papers citing papers by Ewa Lech‐Marańda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Lech‐Marańda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Lech‐Marańda. The network helps show where Ewa Lech‐Marańda may publish in the future.

Co-authors

The 25 scholars most cited alongside Ewa Lech‐Marańda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ewa Lech‐Marańda Line = papers co-authored together Ewa Lech‐Marańda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hit paper breakdown →
20171693
2
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Hit paper breakdown →
2017593
3
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
Hit paper breakdown →
2021365
4
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
Hit paper breakdown →
2023164
5 2004152
6
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
Hit paper breakdown →
2023141
7 2021130
8 2006129
9 2021116
10 202084
11 202377
12 200275
13
Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.
200671
14 200865
15 200961
16 200054
17 202052
18 202252
19 200351
20 201650

About Ewa Lech‐Marańda

Ewa Lech‐Marańda is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Immunology, having authored 197 papers that have together received 5.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (89 papers), Lymphoma Diagnosis and Treatment (59 papers), Acute Lymphoblastic Leukemia research (33 papers), Multiple Myeloma Research and Treatments (27 papers), Chronic Myeloid Leukemia Treatments (20 papers), Acute Myeloid Leukemia Research (19 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Genetics (1.6k citations), Hematology (1.4k citations), Pathology and Forensic Medicine (1.9k citations), Oncology (2.2k citations) and Immunology (1.0k citations). Ewa Lech‐Marańda has collaborated with scholars based in Poland, United States and Australia. Frequent co-authors include Tadeusz Robak, Anna Korycka, Krzysztof Warzocha, Ewa Robak, Anna Wolska, Gilles Salles, Bertrand Coiffier, Agata Wrzesień‐Kuś, Jacques Bienvenu and Pawel J. Robak. Their work appears in journals such as Blood, European Journal Of Haematology, Cancers, Archivum Immunologiae et Therapiae Experimentalis and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact